Literature DB >> 21538668

The use of knockout mice to test the specificity of antibodies for cannabinoid receptors.

John C Ashton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21538668     DOI： 10.1002/hipo.20946

Source DB:  PubMed          Journal:  Hippocampus        ISSN： 1050-9631            Impact factor:   3.899


× No keyword cloud information.
  14 in total

1.  Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus.

Authors:  Y Li; J Kim
Journal:  Neuroscience       Date:  2015-10-26       Impact factor: 3.590

2.  Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors.

Authors:  Femke S den Boon; Pascal Chameau; Qiluan Schaafsma-Zhao; Willem van Aken; Monica Bari; Sergio Oddi; Chris G Kruse; Mauro Maccarrone; Wytse J Wadman; Taco R Werkman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

Review 3.  The endocannabinoid system as a target for novel anxiolytic drugs.

Authors:  Sachin Patel; Mathew N Hill; Joseph F Cheer; Carsten T Wotjak; Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

4.  Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats.

Authors:  Hai-Ying Zhang; Ming Gao; Hui Shen; Guo-Hua Bi; Hong-Ju Yang; Qing-Rong Liu; Jie Wu; Eliot L Gardner; Antonello Bonci; Zheng-Xiong Xi
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

5.  Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina.

Authors:  Bruno Cécyre; Sébastien Thomas; Maurice Ptito; Christian Casanova; Jean-François Bouchard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-05       Impact factor: 3.000

6.  High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.

Authors:  Sofia B Gustafsson; Richard Palmqvist; Maria L Henriksson; Anna M Dahlin; Sofia Edin; Stig O P Jacobsson; Åke Öberg; Christopher J Fowler
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

7.  Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity.

Authors:  Yannick Marchalant; Philip W Brownjohn; Amandine Bonnet; Torsten Kleffmann; John C Ashton
Journal:  J Histochem Cytochem       Date:  2014-03-26       Impact factor: 2.479

8.  Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.

Authors:  Peter S Amenta; Jack I Jallo; Ronald F Tuma; D Craig Hooper; Melanie B Elliott
Journal:  J Neuroinflammation       Date:  2014-11-22       Impact factor: 8.322

Review 9.  Critical appraisal of the potential use of cannabinoids in cancer management.

Authors:  Belinda J Cridge; Rhonda J Rosengren
Journal:  Cancer Manag Res       Date:  2013-08-30       Impact factor: 3.989

Review 10.  Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain.

Authors:  Jean-François Bouchard; Christian Casanova; Bruno Cécyre; William John Redmond
Journal:  Neural Plast       Date:  2015-12-29       Impact factor: 3.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.